Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro
about
Clinical application of adoptive T cell therapy in solid tumorsVariation and significance of secretory immunoglobulin A, interleukin 6 and dendritic cells in oral cancer.A retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung.Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer CellsIncreased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review.A Positive Role of Cytokine-Induced Killer Cell Therapy on Gastric Cancer Therapy in a Chinese Population: A Systematic Meta-Analysis.Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors.Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin.New adoptive immunotherapy strategies for solid tumours with CIK cells.Immunotherapy: a useful strategy to help combat multidrug resistance.Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma.Cytokine-induced killer cells hunt individual cancer cells in droves in a mouse model.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.The role of C/EBP-β LIP in multidrug resistance.Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line.Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
P2860
Q27011283-67761C20-9156-4B16-9F9F-1163E786CBA7Q33598073-4E184A1D-37C4-4718-A5B4-512E4AEDBCEFQ34585228-CBD5250A-35E4-42AB-824F-F7C4FD5CC527Q35543911-EFDCDCA0-A6E2-4D90-BBE5-74E2F2C0966DQ35870544-15792503-CC91-4EA8-BE8B-893E7907A1BFQ36263711-23486D61-3D3F-4448-A6F0-F0220E358AEFQ36618130-8635EED2-7700-4021-9AB7-30456FE2FA81Q36639784-212C1354-67B7-4D68-BF4D-8BF53D02F3A3Q37996561-2B5F0A20-7C59-4C19-9969-F2A553500AA4Q38000768-6894067E-F9BA-4064-87D7-9C5F6A85AD83Q38002494-A81BD920-08A4-4AE1-B66C-4C445D9EAF69Q38201328-CA9A23DD-C2EA-4AAA-9339-DAAFFD7D789BQ39152954-3C3A17F3-5C67-41E0-88D8-EEE23F9F5334Q41110505-4A418CDC-090E-41E0-AC6E-8388C2F2193CQ42474136-929E70C1-1989-43FB-B147-4A5407E98194Q46028686-0CA11459-F40B-40BD-A252-B88618146E9AQ57167306-EA516820-193A-479B-9D14-70F5913DF97E
P2860
Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@ast
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@en
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@nl
type
label
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@ast
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@en
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@nl
prefLabel
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@ast
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@en
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@nl
P2093
P2860
P356
P1476
Anti-tumor effects of CIK comb ...... cer cells in vivo and in vitro
@en
P2093
P2860
P2888
P356
10.1186/1756-9966-29-118
P577
2010-08-30T00:00:00Z
P5875
P6179
1048610565